DrugPatentWatch Database Preview
Profile for United States of America Patent: 2012115950
US Patent Family Members and Approved Drugs for United States of America Patent: 2012115950
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Feb 24, 2023 | Shire Development | VYVANSE | lisdexamfetamine dimesylate |
➤ Try a Free Trial | Feb 24, 2023 | Shire Dev Llc | VYVANSE | lisdexamfetamine dimesylate |
➤ Try a Free Trial | Feb 24, 2023 | Shire Development | VYVANSE | lisdexamfetamine dimesylate |
➤ Try a Free Trial | Feb 24, 2023 | Shire Dev Llc | VYVANSE | lisdexamfetamine dimesylate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |